financetom
Business
financetom
/
Business
/
US Senator investigates GSK for pulling children's asthma inhaler
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Senator investigates GSK for pulling children's asthma inhaler
Jun 27, 2025 6:35 AM

WASHINGTON, June 27 (Reuters) - Democratic U.S. Senator

Maggie Hassan said on Friday she is launching an investigation

into British pharmaceutical giant GlaxoSmithKline's

decision to discontinue a widely used asthma inhaler for

children.

In letters sent on Friday to GSK and its authorized

generic distributor, Prasco Laboratories, and seen by Reuters,

Hassan said the decision to remove Flovent HFA from the market

in January 2024 had contributed to a spike in hospitalizations

and deaths linked to asthma complications.

She demanded documents detailing the rationale behind

the decision, and its financial and health impacts.

Hassan, the top Democrat on the Senate Finance Committee's

Health Care Subcommittee, called on GSK to restore the inhaler

to market. She also requested internal pricing documents, rebate

data, and communications with regulators by July 18.

She accused GSK of evading rebate obligations to Medicaid,

which provides health coverage to 71 million low-income people

and is one of the biggest U.S. safety-net programs. In addition,

GSK's decision to replace the brand-name inhaler with a

higher-cost authorized generic had lowered access for low-income

patients, Hassan said.

"Children across the country have faced life-threatening

medical challenges and families have grappled with more

expensive or less effective alternative medications - when these

options are available at all," Hassan wrote in her letter.

GSK told Hassan in response to an earlier letter she sent in

May last year that Prasco controls pricing of the generic.

Hassan said both companies failed to ensure affordability of the

treatment, contributing to delays or denials of insurance

coverage.

Hassan cited a Johns Hopkins analysis which found that GSK's

move saved the company $367 million in 2024 Medicaid rebates,

while costing the program over $550 million. Parents reported

paying up to $150 per inhaler for the generic, compared to $10

for Flovent.

GSK said last year it would cap out-of-pocket costs for all

its inhaled asthma and chronic lung disease medicines at $35 per

month for eligible patients in the United States starting

January 2025, following similar moves by its rivals.

The announcement came after lawmakers criticized

manufacturers over high prices, and launched an investigation to

look into the prices at which these were sold in the U.S. versus

other countries.

(Reporting by Ahmed Aboulenein; Editing by Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vermilion Energy To Divest Canadian Assets In Move To Cut Debt
Vermilion Energy To Divest Canadian Assets In Move To Cut Debt
May 26, 2025
Vermilion Energy Inc. ( VET ) announced Friday that it will sell its oil and gas assets in Saskatchewan and Manitoba for CA$415 million in cash. The deal supports Vermilion's strategy to streamline its portfolio and improve financial stability. The transaction, expected to close in the third quarter of 2025, will help pay down debt. Vermilion forecasts ending 2025 with...
BRIEF-Blank Check Company Cohen Circle Aqusition Corp. II Files For IPO Of $220 Mln - SEC Filing
BRIEF-Blank Check Company Cohen Circle Aqusition Corp. II Files For IPO Of $220 Mln - SEC Filing
May 26, 2025
May 23 (Reuters) - * BLANK CHECK COMPANY COHEN CIRCLE AQUSITION CORP. II FILES FOR IPO OF $220 MILLION - SEC FILING * COHEN CIRCLE AQUSITION CORP II: CLEAR STREET IS UNDERWRITER TO IPO * COHEN CIRCLE ACQUISITION CORP II: INTENDS TO LIST UNITS ON NASDAQ UNDER THE SYMBOL CCIIU Source text: Further company coverage: [ ] ...
BRIEF-Herc Holdings Extends Tender Offer to Acquire H&E Equipment Services
BRIEF-Herc Holdings Extends Tender Offer to Acquire H&E Equipment Services
May 26, 2025
May 23 (Reuters) - Herc Holdings Inc ( HRI ): * HERC HOLDINGS EXTENDS TENDER OFFER TO ACQUIRE H&E EQUIPMENT SERVICES * HERC HOLDINGS INC ( HRI ) - TENDER OFFER EXTENDED UNTIL MAY 29, 2025 Source text: Further company coverage: ...
BRIEF-UK'S CMA Says Investigating Completed Acquisition By Aramark Limited Of Entier Limited
BRIEF-UK'S CMA Says Investigating Completed Acquisition By Aramark Limited Of Entier Limited
May 26, 2025
May 23 (Reuters) - UK'S CMA : * UK'S CMA SAYS INVESTIGATING COMPLETED ACQUISITION BY ARAMARK LIMITED OF ENTIER LIMITED * UK'S CMA SAYS ARAMARK / ENTIER INVITATION TO COMMENT CLOSES 9 JUNE 2025 Source text: Further company coverage: ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved